Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pathology|June 26, 2019
Cytohistological diagnosis of pancreatic serous cystadenoma: a multimodal approachMichael Steel, Samarth Rao, Julie Ho, et al.
Journal of the Canadian Association of Gastroenterology|June 7, 2022
Living on the EDGE: Canadian Experience With EUS-directed Transgastric ERCP (EDGE) in Patients With Roux-en-Y Gastric Bypass AnatomyRobert L Barclay, Avni Jain, Anne-Sophie Buteau Ferland, et al.
Journal of Clinical Gastroenterology|March 23, 2010
Economic impact of prescreening on gastroenterology outpatient clinic practiceFergal Donnellan, Gavin C Harewood, Daniel Cagney, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|October 31, 2009
JNK mitogen-activated protein kinase limits calcium-dependent chloride secretion across colonic epithelial cellsFergal Donnellan, Niamh Keating, Paul Geoghegan, et al.
International Journal of Colorectal Disease|March 10, 2010
Efficacy and safety of colonic stenting for malignant disease in the elderlyFergal Donnellan, Garret Cullen, Daniel Cagney, et al.
Digestive Diseases and Sciences|June 2, 2018
Colorectal Polyps in Childhood Cancer Survivors Treated with Radiation TherapySammy Au, Vladimir Marquez, Fergal Donnellan, et al.
Endoscopy International Open|May 3, 2021
Severe upper gastrointestinal bleeding is halted by endoscopically delivered self-propelling thrombin powder: A porcine pilot studyNabil Ali-Mohamad, Massimo Cau, James Baylis, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 24, 2021
Hereditary and Inflammatory Bowel Disease-Related Early Onset Colorectal Cancer Have Unique Characteristics and Clinical Course Compared with Sporadic DiseaseArif A Arif, Daljeet Chahal, Gale K Ladua, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|July 18, 2013
In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survivalAlexandra Shingina, Al Moutaz Hashim, Mazhar Haque, et al.
Pageof 5